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ORIGINAL ARTICLE
Background/Aims: Patients with chronic airway lung diseases often experience depression and anxiety, but
little information is available regarding Koreans with these conditions. We thus assessed depression and anxiety
in Korean patients with chronic airway lung diseases. 
Methods: The degree of depression and anxiety in 84 outpatients with chronic obstructive pulmonary disease
(COPD), 37 with asthma, 33 with bronchiectasis, and 73 healthy controls were evaluated by the Beck
Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI). 
Results: The patients with COPD and bronchiectasis had higher BDI scores and were more likely than controls
to experience depression ([COPD, 17; range, 0 to 42; prevalence, 55%], [bronchiectasis, 16; range, 3 to 51;
prevalence, 55%], [controls, 13; range, 0 to 31; prevalence, 30%], p < 0.05). The state-anxiety scores of the
patients were higher than those of the controls, but only the bronchiectasis group demonstrated a higher
frequency of state-anxiety compared with the controls (39 vs. 16%, patients vs. controls, p = 0.015). Among all
patients, 22% presented with concomitant depression and state-anxiety, and 25% demonstrated depression and
trait-anxiety. Depression was positively correlated with both state-anxiety (r = 0.644) and trait-anxiety (r = 0.597,
p < 0.0001). Irrespective of individual diagnosis, post-bronchodilator FEV1 (odds ratio [OR], 0.972; p = 0.027)
and smoking history (OR, 3.894; p = 0.018) were independent risk factors for depression in patients with chronic
airway lung diseases. 
Conclusions: Chronic airway lung diseases are associated with depression and/or anxiety, particularly in those
with a higher airflow limitation and/or history of smoking. (Korean J Intern Med 2010;25:51-57)
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INTRODUCTION
Chronic respiratory conditions are being recognized
with increasing frequency in both Korea and worldwide
[1-3] and are associated with an increased risk for mood
and anxiety disorders [4-7]. Activities of daily living may
be severely impaired in patients with chronic airway lung
diseases owing to chronic psychological stress and somatic
pain, frequent admission to the hospital, and dependence
on medical and nursing personnel. Depression and anxiety
cause deterioration in social functioning and quality of life
and are correlated with levels of subjective dyspnea and
disease progression [8-11]. Thus, detecting depression or
anxiety in patients with chronic airway lung diseases is of
great importance. Although the close correlation between
anxiety and depression is well known, few studies have
examined their simultaneous occurrence in patients with
chronic respiratory conditions. Moreover, studies assessing
and comparing anxiety and depression levels among
patients with different chronic airway lung diseases suchas chronic obstructive pulmonary disease (COPD), bronchial
asthma, and bronchiectasis have been scarce in Korea.
The present cross-sectional study compared the levels
and frequency of anxiety and depression among outpatients
presenting at our pulmonary department with COPD,
bronchial asthma, or bronchiectasis. In addition, we
evaluated the clinical variables associated with depression
in patients with chronic airway lung diseases. 
METHODS
Subjects
We recruited 73 healthy control participants with no
underlying lung disease or respiratory symptoms and 154
outpatients, 45 years of age and older, with chronic airway
lung diseases who presented at the pulmonary department
of our hospital. Of the 154 patients, 84 were diagnosed
with COPD, 37 had bronchial asthma, and 33 had
bronchiectasis. All patients received prior clinical
evaluations and pulmonary function tests. This report
presents the results of a cross-sectional assessment of
depression and anxiety in these outpatients.
Data analysis
Cross-sectional data obtained from measures of
pulmonary function, laboratory values, smoking behavior,
nutrition, age, sex, and symptoms of depression and
anxiety were analyzed for all subjects. The forced vital
capacity (FVC) and forced expiratory volume one second
(FEV1) before and 15 min after inhalation of 400 µg of
salbutamol were determined in terms of pulmonary
function units (SensorMedics, Yorba Linda, CA, USA).
Based on the definition provided by the Global Initiative
for Chronic Obstructive Lung Disease (GOLD) [12], COPD
was defined by a chronic airflow limitation not fully
reversible by bronchodilation. Obstruction was defined as
a post-bronchodilator FEV1/FVC ratio < 0.70, and severity
was classified into four categories according to the post-
bronchodilator FEV1 value calculated as a percentage of
the predicted value for normal subjects: mild obstruction,
FEV1 > 80% of the predicted value; moderate, 50 to 79% of
the predicted value; severe, 30 to 49% of the predicted value;
and very severe, < 30% of the predicted value. Patients
with a FEV1 reversibility of > 12% were excluded. Asthma
was defined as an increase in FEV1 of ≥ 12% and ≥ 200
mL compared to pre-bronchodilator values [13] at the
time of diagnosis. All patients received routine treatment
with inhaled corticosteroids and/or long-acting bron-
chodilators. The patients with bronchiectasis were treated
in our outpatient clinic for symptoms attributable to the
bronchiectasis and were diagnosed by high-resolution
computed tomography of the chest [14]. We excluded
patients who had experienced acute exacerbations in their
underlying chronic airway lung diseases within the past
month.
Anxiety symptoms were evaluated with the State-Trait
Anxiety Inventory (STAI) developed by Spielberger et al.
[15] in 1970, which has been translated and standardized
for use in the Korean population [16]. The STAI consists of
two self-evaluation scales designed to assess state-anxiety
anxiety and trait-anxiety separately. The state-anxiety
anxiety scale evaluates a transitory state-anxiety in which
unpleasant feelings, tension, and intensity vary according
to the situation. The trait-anxiety scale assesses a longer-
term personality characteristic. Each scale contains 20
items, each of which is rated from 1 to 4. Clinically
significant levels of state-anxiety or trait-anxiety were
defined as scores ≥ 50 on the state-anxiety or trait-anxiety
subscale [5,17]. Depression was assessed with the Beck
Depression Inventory (BDI) [18,19], which has been
standardized for and used in the Korean population [20].
The BDI, a self-administered measurement of depression,
has been translated into many languages and validated for
use in several countries, including Korea. The
questionnaire rates 21 items addressing emotional,
cognitive, motivational, physiological, and other symptoms
on a scale from 0 to 3; higher scores reflect more severe
symptoms of depression. In accordance with Jo et al. [21],
a threshold of 16 on the BDI was used to separate patients
with mild or no depression (BDI < 16) from those with
moderate to severe depression (BDI ≥ 16). All subjects
completed the Korean versions of the STAI and BDI.
All participants were informed about the study, and all
provided informed consent for their participation.
Although we did not obtain approval from the institutional
review board, this research was conducted according to
the highest ethical standards and conformed to the 1995
Declaration of Helsinki (as revised in Edinburgh, 2000,
and updated in Tokyo, 2004). This study used data
collected from questionnaires, and the subjects understood
that their refusal to participate would not affect the quality
of their clinical care in any way. After BDI and STAI scores
were determined, the patients were informed of the results.
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SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was
used for the statistical analysis. A p value of < 0.05 was
considered significant. Group comparisons for categorical
variables were performed using Pearson’s chi-square test
or Fisher’s exact test. To compare groups of patients, we
used ANOVAs for normally distributed data and the
Kruskal-Wallis test for non-normally distributed data. For
comparisons between two groups, Student’s t-test and the
Mann-Whitney U test were used for normally and  non-
normally distributed data, respectively. Pearson’s correlation
was used to assess the association between anxiety and
depression. To evaluate the risk factors for depression,
multivariate logistic regression analysis was performed
incorporating all factors that obtained values of p < 0.05
in the bivariate analyses.
RESULTS
General characteristics of patients with chronic
airway lung diseases
The demographic characteristics of the 73 healthy
controls and the 154 patients with chronic airway lung
diseases who completed the study are summarized in
Table 1. The median age of all 227 subjects, 65 years
(range, 45 to 89), was similar in the control and COPD
groups. However, patients with bronchial asthma and
bronchiectasis were slightly younger than were healthy
controls or patients with COPD. 
Prevalence of depression and anxiety in patients
with chronic airway lung diseases
Table 2 shows the median scores on the BDI and both
STAI subscales for patients with COPD, bronchial asthma,
and bronchiectasis. Patients with COPD obtained the
highest depression scores, followed by patients with
bronchiectasis, and then by those with bronchial asthma,
in decreasing order. The BDI scores and frequency of
depression for the healthy controls and the patients with
bronchial asthma did not differ significantly. Depression
was identified in 55% of the patients with COPD (OR, 2.7;
p= 0.004), 55% of those with bronchiectasis (OR, 3.0; p=
0.016), 41% of those with bronchial asthma (OR, 1.5; p =
0.293), and 30% of the healthy controls. In a subgroup
analysis of patients with COPD, increased frequency of
depression was correlated with increased disease severity
according to the GOLD stages (p = 0.004); the frequency
of depression among those with mild disease levels was
23% (5/22); with moderate, 54% (14/26); with severe,
72% (21/29); and with very severe, 71% (5/7). In terms of
the severity categories, 40% (19/48) of the patients with
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Table 1. Baseline characteristics of the study population
Parameters
Chronic airway lung diseases
Healthy control COPD Bronchial asthma Bronchiectasis
(n = 73) (n = 84) (n = 37) (n = 33)
Age, yr 66 (51 - 89) 67 (45 - 88) 56 (45 - 80)a,b 62 (45 - 83)a,b
Male gender 33 (45) 80 (95)a 16 (43)b 15 (46)b
Body mass index, kg/m
2 23.8 ± 3.2 22.6 ± 3.0 24.9 ± 3.6b 21.3 ± 3.3a
Smoking habits
Ex-smoker / Current smoker 14 / 1 59 / 25 7 / 3 9 / 1
Median pack-years 20 (1 - 40) 40 (15 - 100)a 20 (5 - 30)b 18 (2 - 70)b
Post-bronchodilator FVC, % predicted 98.8 ± 14.2 81.9 ± 17.8a 82.8 ± 18.7a 62.6 ± 18.2a,b
Post-bronchodilator FEV1, % predicted 102.7 ± 16.7 59.5 ± 24.8a 71.7 ± 21.1a,b 55.0 ± 19.0a
Post-bronchodilator FEV1/FVC ratio 84.9 ± 10.6 51.9 ± 13.3a 63.2 ± 10.2a,b 64.3 ± 16.6a,b
Hemoglobin, g/dL 13.1 ± 1.6 14.3 ± 1.7a 13.7 ± 1.8 13.2 ± 1.4b
Albumin, g/dL 4.1 ± 0.4 4.1 ± 0.5 4.3 ± 0.5 3.9 ± 0.5
PaO2, mmHg (room air) 88.2 ± 3.6 79.1 ± 16.5 84.7 ± 13.2 77.9 ± 20.3
PaCO2, mmHg (room air) 38.9 ± 3.5 40.8 ± 6.8 39.5 ± 4.7 42.8 ± 10.2a
Values are expressed as the mean ± SD, median (range), or number (%). 
COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume one second.
ap < 0.05 compared to healthy controls.
bp < 0.05 compared to patients with COPD.mild to moderate levels of severity experienced depression,
whereas 72% (26/36) of the patients with severe to very
severe levels of severity experienced this condition (Table 3).
The trait-anxiety scores of patients with chronic airway
lung diseases did not differ significantly from those of
healthy controls, with the exception of the patients with
COPD, who had a median trait-anxiety score of 47 (vs. 44
for the controls, p = 0.042) and a median state-anxiety
score of 44 (vs. 40 for the controls, p = 0.029). Despite
their higher median trait-anxiety score, patients with
COPD were not significantly more likely than healthy
controls to report trait-anxiety (p = 0.054). State-anxiety
was identified in 26% of the patients with COPD (vs. 16%
of the controls, p= 0.176), 16% of the patients with bronchial
asthma (vs. controls, p = 1.000), and 39% of the patients
with bronchiectasis (vs. controls, p= 0.015)  (Table 2). 
Overall, 79 (51%) of the 154 patients with chronic airway
lung diseases exhibited clinically significant levels of
depression according to their BDI scores. Thirty-four
patients (22%) presented with concomitant depression
and state-anxiety anxiety, and 39 (25%) presented with
both depression and trait-anxiety.  
Determinants of depression in patients with
chronic airway and lung diseases
A lower BMI, history of smoking, lower predicted values
of post-bronchodilator FVC and FEV1, and higher PaCO2
levels were more common among chronic airway lung
disease patients with depression than among those without
depression. However, no significant difference between
patients with and without depression was observed with
respect to age, gender, degree of hypoxia, hemoglobin level,
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Table 3. Subgroup analysis of depression and anxiety status in patients with COPD, grouped according to GOLD
staging
Variables
Chronic obstructive pulmonary disease
Healthy control Mild to moderate Severe to very severe
(n = 73) (n = 48) (n = 36)
BDI
Total score 13 (0 - 31) 14 (2 - 34)a 21 (0 - 42)a,b
BDI score ≥ 16  22 (30) 19 (40) 26 (72)a,b
STAI
State-anxiety score 40 (23 - 67) 44 (21 - 63) 48 (20 - 67)a,b
Trait-anxiety score 44 (30 - 90) 46 (28 - 66) 50 (20 - 62)a
Values are expressed as the median (range) or number (%).
COPD, chronic obstructive pulmonary disease; GOLD, global initiative for chronic obstructive lung disease; BDI, Beck Depression
Inventory; STAI, State-Trait Anxiety Inventory. 
ap < 0.05 compared to healthy controls.
bp < 0.05 compared to mild to moderate COPD.
Table 2. Depression and anxiety status of the study population
Variables
Chronic airway lung diseases
Healthy control COPD Bronchial asthma Bronchiectasis
(n = 73) (n = 84) (n = 37) (n = 33)
BDI
Total score 13 (0 - 31) 17 (0 - 42)a 14 (2 - 36) 16 (3 - 51)a
BDI score ≥ 16  22 (30) 46 (55)a 15 (41) 18 (55)a
STAI
State-anxiety score 40 (23 - 67) 44 (20 - 67)a 44 (23 - 67)a 43 (23 - 72)a
Trait-anxiety score 44 (30 - 90) 47 (20 - 66)a 45 (32 - 58) 46 (28 - 64)
Values are expressed as the median (range) or number (%).
COPD, chronic obstructive pulmonary disease; BDI, Beck Depression Inventory; STAI, State-Trait Anxiety Inventory.
ap < 0.05 compared to healthy controls.or serum albumin level. Compared to patients without
depression (BDI < 16), patients with depression (BDI ≥
16) had significantly higher median scores for both
subscales of the STAI (p< 0.0001), and their symptoms of
depression were positively correlated with both state-
anxiety (r= 0.644, p< 0.0001) and trait-anxiety (r= 0.597,
p< 0.0001).
A bivariate analysis identified four variables related to
increased risk for clinically relevant depression (p< 0.05):
BMI (OR, 0.9; p = 0.023), history of smoking (current or
ex-smoker; OR, 2.8; p = 0.004), predicted value of post-
bronchodilator FVC (OR, 0.972; p = 0.002), and predicted
value of post-bronchodilator FEV1 (OR, 0.966; p <
0.0001). Age and sex were added to these four factors in a
multivariate logistic analysis, revealing that the predicted
value of post-bronchodilator FEV1 (OR, 0.972; p = 0.027)
and smoking (current or ex-smoker) (OR, 3.894; p= 0.018)
were independently associated with the development of
depression in patients with chronic airway lung diseases,
irrespective of individual diagnosis (Table 4). 
DISCUSSION
The present study found a higher prevalence of depression
among patients with chronic airway lung diseases than
among those in the healthy control group, but found no
significant difference with respect to the frequency of
anxiety, even though the scores for anxiety symptoms
were higher among the patients with chronic airway lung
diseases than among the controls. Clinically significant
depression was strongly correlated with more severe
airflow limitations and a history of smoking (current or
ex-smokers), which were independent risk factors for
depression in patients with chronic airway lung diseases.
Previous studies have reported a tendency toward
depression in patients with COPD [4-7], and our findings
confirmed a higher frequency of depression in these
patients. In the present study, 70% of patients with
severe to very severe COPD exhibited depression. Higher
percentages of patients with COPD and bronchiectasis
than of controls reported symptoms of depression, although
anxiety was not more common in the patients than in the
controls. Previous studies have reported susceptibility to
depression in patients with other chronic respiratory
conditions [17,22]. Indeed, bronchiectasis manifests as a
chronic and progressive disease with multiple exacerbations
resulting in altered lung functioning, including irreversible
airflow obstruction, progressive dyspnea, and greatly
reduced quality of life [14]. Contrary to the results of
previous studies [17,22], our data showed that the scores
for and frequency of depression in patients with asthma
did not differ significantly from those in members of
the control group. However, irrespective of the specific
pulmonary diagnosis, clinically significant levels of
depression were more common in patients who were
smokers and/or those with airflow limitations that altered
lung functioning.
As established in previous studies [4,22], our results
also showed a significant correlation between anxiety and
depression. The state-anxiety scale evaluates a momentary
condition in which the intensity of unpleasant feelings
depends on the situation. Thus, because state-anxiety
anxiety represents symptoms at the moment of
evaluation, the groups with chronic airway lung diseases
would be expected to have higher state-anxiety scores
than would those in the control group [17]. The trait-
anxiety scores of patients and healthy controls, however,
did not differ significantly, and the frequency of trait-
anxiety in patients and controls was similar. This finding
can be attributed to the fact that the trait-anxiety scale
measures a lasting personality trait-anxiety related to how
an individual responds to potentially threatening
situations over the course of a lifetime.
The dearth of studies with adequate sample sizes and
the variability in the instruments and threshold scores
used to measure depression and anxiety have been
recognized as difficulties in developing strategies to
manage Korean patients with chronic airway lung diseases.
A BDI score of 21 has been suggested as the optimal cutoff
score for the diagnosis of major depression because it is 1
standard deviation from the mean in a Korean cohort
[20]. However, a recent study reported that a cutoff score
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Table 4. Predictive factors for depression in patients
with chronic airway lung diseases
Factors Odds ratio (95% CI) p value
Age 1.017 (0.978 - 1.059) 0.395
Female gender  1.792 (0.579 - 5.547) 0.311
Body mass index 0.974 (0.865 - 1.095) 0.656
Current or ex-smoker  3.894 (1.269 - 11.952) 0.018
Post-bronchodilator FVC, % predicted 0.990 (0.961 - 1.020) 0.522
Post-bronchodilator FEV1, % predicted 0.972 (0.947 - 0.997) 0.027
CI, confidence interval; FVC, forced vital capacity; FEV1, forced
expiratory volume one second.of 16 on the Korean version of the BDI was reliable in
screening elderly patients for depression [21]. Based on a
study by Jo et al. [21], the present study used a score of 16
as the optimal threshold for the diagnosis of clinically
significant depression because our study group included
elderly patients. Unfortunately, clinical cutoff scores for
the STAI subscales have not been validated in the Korean
population; therefore, we diagnosed anxiety according to
previous work performed by Carvalho et al. [17].
Patients with a higher degree of airflow limitation, as
determined by measuring the post-bronchodilator FEV1,
reported more symptoms of depression, and pulmonary
functioning was found to be a predictor of depression.
Patients with severe airway obstruction have previously
been shown to face increased risk for depression [7,23],
and several studies have identified a history of smoking as
a strong risk factor for depression [24,25]. Similarly, our
results also demonstrated that a history of smoking was
associated with increased risk for depression in patients
with chronic airway lung diseases. The complex behaviors
associated with nicotine addiction are often accompanied
by comorbid depression or depressive symptoms [26,27],
although the reasons for this association are not well
understood. The present study showed no correlation
between depression or anxiety and age, sex, nutritional
status, or degree of hypoxia or hypercapnia. Our results
underscore the importance of screening for and treating
depression and anxiety in patients with chronic airway
lung diseases so that they may retain their functional
status, avoid unnecessary hospitalizations, and maintain
their efforts at pulmonary rehabilitation [8-11]. Currently,
depression is underdiagnosed in this patient population.
Because depression is associated with deterioration in the
underlying lung disease and increased mortality, it must
be assessed in patients with chronic respiratory conditions.
Although this is, to date, the largest series evaluating the
frequency and risk factors associated with depression and
anxiety in Korean patients with chronic respiratory
conditions, this study has certain limitations. We did not
assess or measure functional status or health-related
quality of life in our subjects and were therefore unable to
examine correlations between these factors and psycho-
logical distress. Furthermore, we did not assess personal
characteristics such as standard of living, educational
level, economic conditions, and family issues, all of which
have an influence on psychological distress. From a
clinical perspective, these variables are difficult to measure
in the outpatient setting of a pulmonary clinical practice. 
In conclusion, patients with chronic respiratory diseases
are at increased risk for depression and anxiety. Decreased
lung function with airflow limitations and a history of
smoking were independent risk factors for depression in
patients with chronic airway lung diseases. Our findings
show that the importance of screening for depression is
underscored in patients with chronic airway lung diseases,
particularly those with a high airflow limitation or history
of smoking, to provide adequate patient care. Further
studies are needed to elucidate the effectiveness of treating
psychiatric distress in these patients as well as the efficacy
of screening to identify those who might benefit from
specific therapy. 
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